Chargement en cours...
Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses
We analyzed cost-effectiveness studies related to hematologic malignancies from the Tufts Medical Center Cost-Effectiveness Analysis Registry (www.cearegistry.org), focusing on studies of innovative therapies. Studies that met inclusion criteria were categorized by 4 cancer types (chronic myeloid le...
Enregistré dans:
| Publié dans: | Blood |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4366623/ https://ncbi.nlm.nih.gov/pubmed/25655601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-07-592832 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|